BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Provectus Biopharmaceuticals Inc. Will Hold Its 2014 Year-End Quarterly Business Update Conference Call At 4 PM Eastern, Thursday, March 12, 2015 2/24/2015 10:47:46 AM
Provectus Biopharmaceuticals Inc. Will Present at 8th Annual European Life Science CEO Forum & Exhibition 2/18/2015 1:49:39 PM
Provectus Biopharmaceuticals Inc. Release: Late Melanoma Patients Will Need Several Lines of Therapy, Intralesional Treatment Promising Says New Paper 2/12/2015 12:21:20 PM
Provectus Biopharmaceuticals Inc. Will Present At 17th Annual BIO CEO And Investor Conference Tuesday, February 10, 2015 2/10/2015 12:07:35 PM
Provectus Biopharmaceuticals Inc. Met With FDA On Operational Aspects Of PV-10 Phase 3 Melanoma Study 2/9/2015 10:31:01 AM
Provectus Biopharmaceuticals Inc.’s PV-10 Featured In Article By Sanjiv Agarwala In Current Opinion In Oncology 2/6/2015 10:50:18 AM
Provectus Biopharmaceuticals Inc. Begins Recruitment For Phase 2 Mechanism Of Action Clinical Trial Of PH-10 For Psoriasis 1/29/2015 10:44:57 AM
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015 10:02:53 AM
Provectus Biopharmaceuticals Inc.’ Protocol For Phase 2 Study Of Mechanism Of Action Of PH-10 On Immunologic Makers Of Psoriasis Now Available Online 12/23/2014 10:36:24 AM
Provectus Biopharmaceuticals Inc. To Meet With FDA On Operational Aspects Of PV-10 Phase 3 Melanoma Study With Aim To Maximize Speed Of Enrollment 12/22/2014 11:45:42 AM
12345678910...